Technical Analysis for 0R91 - Mithra Pharmaceuticals S.A.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 0.22 | -1.13% | 0.00 |
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Very Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 20 DMA Resistance | Bearish | 0.00% | |
| 200 DMA Resistance | Bearish | 0.00% | |
| 50 DMA Resistance | Bearish | 0.00% | |
| Shooting Star Candlestick | Bearish | 0.00% | |
| Lizard Bearish | Bearish Day Trade Setup | 0.00% | |
| Expansion Pivot Sell Setup | Bearish Swing Setup | 0.00% | |
| Doji - Bearish? | Reversal | 0.00% | |
| Doji - Bullish? | Reversal | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Upper Bollinger Band Touch | Strength | 0.00% |
Get a Trading Assistant
Mithra Pharmaceuticals S.A. Description
Mithra Pharmaceuticals SA develops, manufactures, and markets complex therapeutics in the areas of contraception, menopause, and hormone-dependent cancers in Belgium, Europe and internationally. Its development candidates include Estelle, a combined oral contraceptive that has completed phase III clinical trial; Donesta, which is in phase III clinical trial for estetrol-based oral hormone treatment; and products for neuroprotection and wound healing. The company also develops Myring, a contraceptive vaginal ring releasing a combination of hormones; Tibelia, a tablet composed of tibolone and a synthetic steroid used for hormone therapy in menopause; and Zoreline, a biodegradable subcutaneous implant for use in prostate and breast cancers, and benign gynecological indications. In addition, it provides products in polymeric forms, implants, sterile injectable products, and hormonal tablets. The company was founded in 1999 and is headquartered in Liège, Belgium.
Classification
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 3.9 |
| 52 Week Low | 0.2076 |
| Average Volume | 16,544 |
| 200-Day Moving Average | 1.56 |
| 50-Day Moving Average | 0.60 |
| 20-Day Moving Average | 0.23 |
| 10-Day Moving Average | 0.23 |
| Average True Range | 2.27 |
| RSI (14) | 20.00 |
| ADX | 61.18 |
| +DI | 1.75 |
| -DI | 0.43 |
| Chandelier Exit (Long, 3 ATRs) | -4.06 |
| Chandelier Exit (Short, 3 ATRs) | 7.01 |
| Upper Bollinger Bands | 0.28 |
| Lower Bollinger Band | 0.19 |
| Percent B (%b) | 0.32 |
| BandWidth | 36.63 |
| MACD Line | -0.09 |
| MACD Signal Line | -0.11 |
| MACD Histogram | 0.0254 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 4.01 | ||||
| Resistance 3 (R3) | 4.43 | 3.59 | 3.38 | ||
| Resistance 2 (R2) | 3.59 | 2.62 | 3.38 | 3.17 | |
| Resistance 1 (R1) | 1.90 | 2.03 | 1.48 | 1.48 | 2.96 |
| Pivot Point | 1.06 | 1.06 | 0.85 | 0.85 | 1.06 |
| Support 1 (S1) | -0.62 | 0.10 | -1.04 | -1.04 | -2.52 |
| Support 2 (S2) | -1.47 | -0.50 | -1.68 | -2.73 | |
| Support 3 (S3) | -3.15 | -1.47 | -2.94 | ||
| Support 4 (S4) | -3.57 |
